rs227727

This is a regulatory region variant variant.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

serum creatinine amount

Allele T
OR 0.01
p 1.0e-20
N 394,642
Large GWAS
European
Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele T
OR 0.01
p 3.0e-17
N 494,370
Large GWAS
multi-ancestry
Zoodsma M et al. A genetic map of human metabolism across the allele frequency spectrum. Nature Genetics 57(10):2445-2455 (2025)
Allele T
OR 0.01
p 8.0e-14
N 450,015
Large GWAS
multi-ancestry

lip morphology trait

White JD et al. Insights into the genetic architecture of the human face. Nature Genetics 53(1):45-53 (2021)
Allele T
OR
p 1.0e-16
N 4,680
Large GWAS
European

snoring measurement

Allele A
OR 0.01
p 2.0e-9
N 407,066
Major Consortium StudyLarge GWAS
European

glomerular filtration rate

Allele T
OR 0.01
p 3.0e-10
N 406,504
Large GWAS
European

Research that mentions this SNP (1)

Genetic risk factors for orofacial clefts in Central Africans and Southeast Asians
AssociationN=993Jane C. Figueiredo et al.(2014)· American Journal of Medical Genetics Part A

A targeted genome-wide study examining SNPs in three understudied populations (260 children with orofacial clefts from the DRC, Vietnam, and Philippines) confirmed four cleft susceptibility regions: 1q32.2 (IRF6), 10q25.3 (VAX1), 17q22 (NOG), and 15q13.3. Notable findings include rs10787738 near VAX1 (P=4.98E-03) and rs7987165 on chromosome 13 (P=2.2E-05) in meta-analysis, with risk alleles varying by population and no significant associations found in African populations.

Traits studied:Cleft lip with or without cleft palateNon-syndromic cleft lipNon-syndromic cleft palateOrofacial clefts

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…